APGE
NASDAQ · Biotechnology
Apogee Therapeutics Inc
$135.07
-0.01 (-0.01%)
Analyst Consensus
Hold
21
Analysts
High
Coverage
Price Target
Analyst Price Target
-24.8% upside
Low Target
$78.76
Average Target
$101.57
High Target
$153.22
Current Price
$135.07
Current
$135.07
$135.07
Target
$101.57
$101.57
$78.76
$101.57 avg
$153.22
Scenario Analysis
Bear Case
$78.76
-41.7%
Low target
Base Case
$101.57
-24.8%
Avg target
Bull Case
$153.22
+13.4%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$135.09
0.0% from high
52-Week Low
$52.34
+158.1% from low
50-Day SMA
$84.66
+59.5% vs SMA
200-Day SMA
$67.12
+101.2% vs SMA
RSI (14)
81.2
Overbought
Target vs 52W High
$101.57
-24.8% vs high
Next Earnings Report
Nov 9, 2026
Today
EPS Est: $-1.17
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.2% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -46.0% |
| REGN | Buy | 36 | 72% | $76.80 | -91.7% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -42.6% |